Odyssey Health, Inc. Successfully Completes Phase I Single Ascending Dosing for Intranasal Concussion Drug
12 juil. 2022 08h00 HE
|
Odyssey Health, Inc
Las Vegas, NV, July 12, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical...
Global Synthetic Biology: DNA Cloning Market Report (2022 to 2035) - by Type of Cloning Method, End-Users and Key Geographical Regions
16 juin 2022 05h08 HE
|
Research and Markets
Dublin, June 16, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology: DNA Cloning Market by Type of Cloning Method, End-Users and Key Geographical Regions: Industry Trends and Global Forecasts,...
Patient Engagement Solutions Market worth $27.9 billion by 2027 - Report by MarketsandMarkets™
10 juin 2022 11h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, June 10, 2022 (GLOBE NEWSWIRE) -- According to the new market research report "Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy...
Aditxt Engages IBN (InvestorBrandNetwork) To Bolster Its Corporate Communications Efforts
09 juin 2022 08h30 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, June 09, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – Aditxt, Inc. (“Aditxt” or “the Company”) (NASDAQ: ADTX), a biotech innovation company, today announces it has selected the corporate...
SinuSonic Announces Presentation of Double-Blind, Sham-Controlled Trial Data Showing Regular Use of the Device Improved Nasal Congestion
26 mai 2022 12h31 HE
|
Healthy Humming, LLC
COLUMBIA, S.C., May 26, 2022 (GLOBE NEWSWIRE) -- SinuSonic, a brand of Healthy Humming, LLC, is pleased to announce the presentation of the results from their study on "Double-blind, sham-controlled...
The Everest Foundation Praises New Atherosclerosis Research
24 mai 2022 12h39 HE
|
Good Guy News
Los Angeles, California, USA, May 24, 2022 (GLOBE NEWSWIRE) -- Good Guy News reports on The Everest Foundaiton funding new artherosclerosis research. Albert Einstein College of Medicine has...
Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada
19 mai 2022 08h30 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, May 19, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health...
Kevin Phelps, CPA Appointed Chief Operating Officer of Arev Life Sciences Global Corporation & Warrant Offering
21 avr. 2022 17h15 HE
|
AREV Life Sciences Global Corp.
VANCOUVER, BC , April 21, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation...
AREV Life Sciences Global Corporation announces engagement of TransBIOTech to facilitate preclinical therapeutic pipeline development
21 avr. 2022 16h52 HE
|
AREV Life Sciences Global Corp.
VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) announced today its initial...
Isracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products Officers
13 avr. 2022 08h30 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the...